Correlation Between Inhibrx and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Inhibrx and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Sonnet Biotherapeutics.
Diversification Opportunities for Inhibrx and Sonnet Biotherapeutics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Inhibrx and Sonnet is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Inhibrx and Sonnet Biotherapeutics
Given the investment horizon of 90 days Inhibrx is expected to generate 0.79 times more return on investment than Sonnet Biotherapeutics. However, Inhibrx is 1.27 times less risky than Sonnet Biotherapeutics. It trades about -0.01 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.58 per unit of risk. If you would invest 1,555 in Inhibrx on September 3, 2024 and sell it today you would lose (29.00) from holding Inhibrx or give up 1.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Inhibrx |
| Sonnet Biotherapeutics |
Inhibrx and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Sonnet Biotherapeutics
The main advantage of trading using opposite Inhibrx and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Inhibrx vs. DiaMedica Therapeutics | Inhibrx vs. Lyra Therapeutics | Inhibrx vs. Centessa Pharmaceuticals PLC |
| Sonnet Biotherapeutics vs. DiaMedica Therapeutics | Sonnet Biotherapeutics vs. Lyra Therapeutics | Sonnet Biotherapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |